Valuation: Becton, Dickinson and Company

Market Cap 42.96B 37.62B 34.73B 32.43B 61.05B 4,062B 62.44B 418B 161B 2,004B 161B 158B 6,957B P/E 2026 *
38.9x
P/E 2027 * 30x
Enterprise Value 58.92B 51.59B 47.62B 44.47B 83.72B 5,570B 85.62B 573B 221B 2,748B 221B 216B 9,541B EV / Sales 2026 *
3.07x
EV / Sales 2027 * 2.89x
Free-Float
74.04%
Yield 2026 *
2.47%
Yield 2027 * 2.51%
1 day-1.12%
1 week+9.52%
Current month+4.75%
1 month+4.75%
3 months-0.37%
6 months-21.03%
Current year-20.59%
1 week 141.25
Extreme 141.25
156.89
1 month 140.11
Extreme 140.11
156.89
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
287.32
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Chief Tech/Sci/R&D Officer - 29/11/2021
Director TitleAgeSince
Director/Board Member 65 26/03/2025
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Date Insider Type Main position Quantity % Market Cap.
26/06Sell

Executive/Senior Manager

-75 0.0000%
24/06Sell

Executive/Senior Manager

-1,100 0.0004%
22/06Other

EVP and Chief People Officer

39,984 0.0145%
Change 5-day change 1-year change 3-year change Capi.($)
-1.10%+9.52%-10.53%-40.85% 42.96B
-0.08%+7.12%-30.83%-12.61% 164B
+0.58%+2.79%-6.53%-6.10% 104B
-0.62%+4.89%-5.10%+49.35% 55.67B
+0.90%-5.29%+52.20%+53.60% 52.92B
+1.18%+13.45% - - 32.87B
-0.66%+0.59%-20.40%-45.69% 27.07B
-0.27%+5.88%+59.56%-7.49% 24.79B
-0.36%+7.49%-10.33%-2.53% 21.02B
+1.58%+1.01%-17.01%-0.71% 20.18B
Average +0.10%+3.38%+1.22%-1.45% 54.51B
Weighted average by Cap. +0.07%+3.81%-6.52%-0.70%

Financials

2026 *2027 *
Net sales 19.21B 16.82B 15.52B 14.5B 27.29B 1,816B 27.91B 187B 72.12B 896B 72.12B 70.54B 3,110B 19.71B 17.26B 15.93B 14.88B 28.01B 1,864B 28.65B 192B 74.02B 919B 74.02B 72.4B 3,192B
Net income 1.12B 985M 909M 849M 1.6B 106B 1.63B 10.94B 4.22B 52.46B 4.22B 4.13B 182B 1.45B 1.27B 1.17B 1.09B 2.06B 137B 2.11B 14.1B 5.44B 67.59B 5.44B 5.32B 235B
Net Debt 15.95B 13.97B 12.9B 12.04B 22.67B 1,508B 23.19B 155B 59.91B 744B 59.92B 58.6B 2,584B 14.07B 12.32B 11.38B 10.62B 20B 1,330B 20.45B 137B 52.84B 656B 52.85B 51.69B 2,279B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
30/06/26 USD 154.09 -1.18% 674,408
26/06/26 USD 155.92 +3.00% 12,180,748
25/06/26 USD 151.38 +2.44% 2,548,949
24/06/26 USD 147.77 +2.68% 2,300,230
23/06/26 USD 143.92 +2.28% 2,908,134
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
155.92USD
Average target price
177.75USD
Spread / Average Target
+14.00%

Quarterly revenue - Rate of surprise